Skip to Content
AP National Business

Atara Biotherapeutics: Q4 Earnings Snapshot

KION
By
Published 1:21 PM

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a loss of $74.6 million in its fourth quarter.

The Thousand Oaks, California-based company said it had a loss of 72 cents per share.

The drug developer posted revenue of $221,000 in the period.

For the year, the company reported that its loss narrowed to $228.3 million, or $2.24 per share. Revenue was reported as $63.6 million.

Atara Biotherapeutics shares have risen 54% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.04, a decrease of 67% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content